Alzheimer's disease diagnostics could become more accessible

by National University of Science and Technology MISISNational University of Science and Technology MISISA team of researchers from the Laboratory of Biophysics at NUST MISIS, Lomonosov Moscow State U

Updated on: April 08,2024 12

Alzheimer's disease diagnostics could become more accessible

by National University of Science and Technology MISISNational University of Science and Technology MISISA team of researchers from the Laboratory of Biophysics at NUST MISIS, Lomonosov Moscow State U

Updated on:April 08,2024 12

Sound stimulation aids saccular dysfunction with Meniere disease

by Lori Solomon and Marianne Madeiros sSound stimulation of 75 dB at a frequency of 100 Hz leads to improvement in cervical vestibular-evoked myogenic potential (cVEMP) amplitude in patients with defi

Updated on: July 05,2024 0

Sound stimulation aids saccular dysfunction with Meniere disease

by Lori Solomon and Marianne Madeiros sSound stimulation of 75 dB at a frequency of 100 Hz leads to improvement in cervical vestibular-evoked myogenic potential (cVEMP) amplitude in patients with defi

Updated on:July 05,2024 0

Use of TNF alpha inhibitors in Crohn's disease associated with higher risk of MS

by Hillary Smith,University of KentuckyDr. Jay Avasarala, professor of neurology and director of UK’s Multiple Sclerosis Clinic, and co-authors, conducted a retrospective study in which they eva

Updated on: May 21,2024 8

Use of TNF alpha inhibitors in Crohn's disease associated with higher risk of MS

by Hillary Smith,University of KentuckyDr. Jay Avasarala, professor of neurology and director of UK’s Multiple Sclerosis Clinic, and co-authors, conducted a retrospective study in which they eva

Updated on:May 21,2024 8

Study reveals the possibility of curbing synapse loss in Alzheimer's

by Children's Hospital BostonThis schematic shows how beta-amyloid (Aß) oligomers, the classical complement cascade and microglia work together to induce synapse loss in the pre-plaque Alzhei

Updated on: February 28,2024 15

Study reveals the possibility of curbing synapse loss in Alzheimer's

by Children's Hospital BostonThis schematic shows how beta-amyloid (Aß) oligomers, the classical complement cascade and microglia work together to induce synapse loss in the pre-plaque Alzhei

Updated on:February 28,2024 15

Testing for inflammatory proteins can help diagnose progression of Alzheimer's disease

by Modesta (Maud) Alobawone,Rutgers UniversityPET scan of a human brain with Alzheimer's disease. Credit: public domainTesting for some inflammatory proteins associated with the nervous and

Updated on: June 20,2024 6

Testing for inflammatory proteins can help diagnose progression of Alzheimer's disease

by Modesta (Maud) Alobawone,Rutgers UniversityPET scan of a human brain with Alzheimer's disease. Credit: public domainTesting for some inflammatory proteins associated with the nervous and

Updated on:June 20,2024 6

Most Medicare beneficiaries say they don't receive cognitive assessments

by Orli Belman,University of Southern CaliforniaCredit: CC0 Public DomainNew research from the University of Southern California measured the use of Medicaid's annual wellness visits and the

Updated on: May 13,2024 4

Most Medicare beneficiaries say they don't receive cognitive assessments

by Orli Belman,University of Southern CaliforniaCredit: CC0 Public DomainNew research from the University of Southern California measured the use of Medicaid's annual wellness visits and the

Updated on:May 13,2024 4

Signals from muscle protect from dementia

by St. Jude Children's Research HospitalResearch in the lab of Fabio Demontis, PhD, of Developmental Neurobiology, used immunostaining and confocal microscopy on fruit fly brain and retina ce

Updated on: June 14,2024 6

Signals from muscle protect from dementia

by St. Jude Children's Research HospitalResearch in the lab of Fabio Demontis, PhD, of Developmental Neurobiology, used immunostaining and confocal microscopy on fruit fly brain and retina ce

Updated on:June 14,2024 6

Alzheimer's meds are mostly tested in whites. That worries Black patients, caregivers

by Sydney MurphyLarry Griner resigned from his job in California and moved back to his childhood home in Baltimore nearly five years ago so he could care for his mother, Norma.She had been diagnosed w

Updated on: April 08,2024 11

Alzheimer's meds are mostly tested in whites. That worries Black patients, caregivers

by Sydney MurphyLarry Griner resigned from his job in California and moved back to his childhood home in Baltimore nearly five years ago so he could care for his mother, Norma.She had been diagnosed w

Updated on:April 08,2024 11

Study shows that 'transcendent' thinking may grow teens' brains over time

byUniversity of Southern CaliforniaDepiction of coronal, sagittal, and axial views of the group-level default mode network (DMN; top) and left executive control network (left ECN; bottom) maps,

Updated on: March 28,2024 0

Study shows that 'transcendent' thinking may grow teens' brains over time

byUniversity of Southern CaliforniaDepiction of coronal, sagittal, and axial views of the group-level default mode network (DMN; top) and left executive control network (left ECN; bottom) maps,

Updated on:March 28,2024 0

New approaches to understanding Alzheimer's and Parkinson's disease

by Alzheimer's Research UKIn a study presented today at the Alzheimer's Association International Conference 2016, researchers at the Douglas Mental Health University Institute have explo

Updated on: March 07,2024 15

New approaches to understanding Alzheimer's and Parkinson's disease

by Alzheimer's Research UKIn a study presented today at the Alzheimer's Association International Conference 2016, researchers at the Douglas Mental Health University Institute have explo

Updated on:March 07,2024 15

Drug that slows progression of ALS may provide the same benefit for people with Alzheimer's disease

by Alzheimer's Drug Discovery FoundationCredit: Unsplash/CC0 Public DomainRiluzole, a drug that has been used for more than 20 years to slow the progression of ALS, commonly known as Lou Gehrig&#3

Updated on: June 20,2024 6

Drug that slows progression of ALS may provide the same benefit for people with Alzheimer's disease

by Alzheimer's Drug Discovery FoundationCredit: Unsplash/CC0 Public DomainRiluzole, a drug that has been used for more than 20 years to slow the progression of ALS, commonly known as Lou Gehrig&#3

Updated on:June 20,2024 6

FDA approves Miplyffa for treatment of Niemann-Pick disease, type C

by Lori SolomonThe U.S. Food and Drug Administration has approved Zevra Therapeutics' Miplyffa (arimoclomol), an oral medication for the treatment of Niemann-Pick disease, type C (NPC).Miplyffa, i

Updated on: November 11,2024 0

FDA approves Miplyffa for treatment of Niemann-Pick disease, type C

by Lori SolomonThe U.S. Food and Drug Administration has approved Zevra Therapeutics' Miplyffa (arimoclomol), an oral medication for the treatment of Niemann-Pick disease, type C (NPC).Miplyffa, i

Updated on:November 11,2024 0